Skip to main content
SOLARA ACTIVE PHARMA SCIENCES LIMITED logo

SOLARA ACTIVE PHARMA SCIENCES LIMITED — Investor Relations & Filings

Ticker · SOLARA ISIN · INE624Z01016 LEI · 3358008SUKH3YE2F7F81 BSE.NS Manufacturing
Open in API
Filings indexed 688 across all filing types
Latest filing 2026-06-10 Regulatory Filings
Country IN India
Listing BSE.NS SOLARA

About SOLARA ACTIVE PHARMA SCIENCES LIMITED

https://www.solara.co.in/

Solara Active Pharma Sciences Limited is a customer-centric organization specializing in the development and manufacturing of active pharmaceutical ingredients (APIs). The company offers a diverse portfolio of high-quality products across therapeutic categories such as pain management, central nervous system, and anti-infectives. It operates several manufacturing sites and research centers that comply with global regulatory standards, including the USFDA and EUGMP. Beyond its commercial API catalog, the company provides comprehensive contract development and manufacturing organization (CDMO) services, assisting partners from the initial research phase to large-scale production. Known for its significant production capacity in key molecules like Ibuprofen, the company focuses on delivering complex and niche APIs to global markets through advanced technical expertise and a commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Clarification in relation to the Email received from BSE on June 10, 2026 on Volume movement.
Regulatory Filings Classification · 85% confidence The document is a formal disclosure letter addressed to BSE Limited’s Surveillance Team in response to a query about a significant increase in trading volume, referencing SEBI (Listing Obligations and Disclosure Requirements) Regulation 30. It contains no financial statements or substantive report content, but rather a compliance/clarification notice under listing regulations. This fits the ‘Regulatory Filings (RNS)’ category for general regulatory announcements and compliance documents.
2026-06-10 English
Spurt in Volume
Regulatory Filings Classification · 85% confidence The document is a letter from the company secretary to the stock exchange responding to a surveillance query under SEBI LODR regulations about increased trading volume. It is a routine regulatory compliance announcement rather than a financial report, earnings release, or other specific filing type. It fits best under General Regulatory Filings (RNS).
2026-06-10 English
Updates
Regulatory Filings Classification · 85% confidence The document is an intimation letter dated June 5, 2026, addressed to the BSE and NSE under SEBI regulatory requirements. It notifies investors of a special window for transfer and dematerialisation of physical securities and refers to SEBI circulars and required forms. There is no substantive financial data, no earnings figures, and no formal report or meeting materials. It is a routine compliance announcement under SEBI regulations and does not fit into any specialized category such as dividends, M&A, or board changes. Therefore, it falls under general regulatory announcements (Regulatory Filings).
2026-06-05 English
Solara Active Pharma Sciences Limited has informed the exchange regarding the Special Window for Transfer and Dematerialisation of shares
Regulatory Filings Classification · 80% confidence The document is a formal notice to the stock exchanges under SEBI regulation informing shareholders of a special window for transfer and dematerialisation of physical shares and providing related process and form details. It does not contain financial statements, earnings data, or constitute a proxy/AGM material; it is a regulatory announcement filed for compliance. Therefore it falls under the catch-all “Regulatory Filings” category.
2026-06-05 English
Solara Active Pharma Sciences Limited has informed the exchange regarding the submission of Annual Secretarial Compliance Report for the fInancial year ended March 31, 2026
Regulatory Filings Classification · 93% confidence The document is a formal “Annual Secretarial Compliance Report” issued under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 by a practicing Company Secretary. It primarily constitutes a statutory compliance certificate/attestation rather than the substantive financial or management report itself. It does not contain actual financial statements or performance data and serves as an officer certification/filing under regulatory requirements. Per the “CERTIFICATION RULE” and fallback guidance, such attestation letters are classified as general regulatory filings. Therefore, the appropriate category is Regulatory Filings (RNS).
2026-05-29 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 90% confidence The document is a statutory disclosure made by the promoter group under Regulation 31(4) of SEBI’s Substantial Acquisition of Shares and Takeovers Regulations, 2011, notifying the stock exchanges that no encumbrance has been created on the company’s shares. It contains no financial statements and is a regulatory compliance announcement, not a full report or capital transaction. This fits the “Regulatory Filings” category (RNS) for miscellaneous compliance disclosures.
2026-05-27 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.